Atypical Antipsychotics Get Poor Grade for Alzheimer's Psychoses
October 11th 2006LOS ANGELES -- Two of three atypical antipsychotic drugs were no better than placebo at quieting aggression, psychosis, and agitation in patients with Alzheimer's disease, found a multicenter trial. Overall, adverse effects of all three outweighed the benefits.
Thalidomide Analog Reduces Transfusion Needs in MDS Patients
October 5th 2006TAMPA, Fla. -- Patients with severe refractory anemia caused by myelodysplastic syndrome (MDS) with a 5q31 deletion could reduce or halt transfusion dependency after treatment with Revlimid (lenalidomide), reported investigators here.